Skip to main content
Fig. 1 | Pediatric Rheumatology

Fig. 1

From: Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study

Fig. 1

Distribution of serum trough concentrations of IFX in a cohort of pediatric autoimmune disorder patients receiving maintenance IFX infusions. The resulting histogram displays the percentage of patients in the experimental cohort (n = 97) with trough serum IFX concentrations in the ranges indicated

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096